NCT03943004View on ClinicalTrials.gov

Trial of DFP-14927 in Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

March 1, 2026

Study Completion Date

June 1, 2026

Conditions
Solid TumorCancer
Interventions
DRUG

DFP-14927

DFP-14927 is a large 4-arm-PEGylated-DFP-10917 molecule. DFP-10917 is a nucleoside analog similar to deoxycytidine.

Trial Locations (2)

77030

RECRUITING

MD Anderson Cancer Center, Houston

90095

RECRUITING

UCLA Department of Medicine- Hematology/Oncology, Los Angeles

Sponsors
All Listed Sponsors
lead

Delta-Fly Pharma, Inc.

INDUSTRY

NCT03943004 - Trial of DFP-14927 in Advanced Solid Tumors | Biotech Hunter | Biotech Hunter